Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy

Not yet recruitingOBSERVATIONAL

Enrollment

114

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

July 30, 2027

Conditions

Effect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy

Interventions

DRUG

Dapagliflozin 10mg Tab or Empagliflozin 10 mg Tab

SGLT-2 inhibitors

All Listed Sponsors

lead

Assiut University

OTHER

NCT06668753 - Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy | Biotech Hunter | Biotech Hunter